Pharmesis International Ltd. (SGX:BFK)
0.4150
0.00 (0.00%)
At close: Oct 29, 2025
Pharmesis International Revenue
Pharmesis International had revenue of 27.20M CNY in the half year ending June 30, 2025, a decrease of -1.79%. This brings the company's revenue in the last twelve months to 70.98M, up 69.75% year-over-year. In the year 2024, Pharmesis International had annual revenue of 67.65M with 48.24% growth.
Revenue (ttm)
70.98M CNY
Revenue Growth
+69.75%
P/S Ratio
1.04
Revenue / Employee
64.76K CNY
Employees
1,096
Market Cap
13.16M SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 67.65M | 22.01M | 48.24% |
| Dec 31, 2023 | 45.64M | -4.73M | -9.40% |
| Dec 31, 2022 | 50.37M | -2.40M | -4.55% |
| Dec 31, 2021 | 52.77M | 5.66M | 12.01% |
| Dec 31, 2020 | 47.11M | 9.91M | 26.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wilmar International | 88.29B |
| Jardine Matheson Holdings | 45.30B |
| DBS Group Holdings | 22.10B |
| Singapore Airlines | 19.54B |
| Singapore Telecommunications | 14.13B |
| Oversea-Chinese Banking Corporation | 13.72B |
| United Overseas Bank | 13.32B |
| Singapore Technologies Engineering | 11.67B |